We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:TVTX
​
​
logo

Travere Therapeutics (TVTX)

Nasdaq • TVTX • US89422G1076

52.42Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Nov 3, 2026, ORTEX estimates 11.5% of free float is sold short, 4.6 days to cover, cost to borrow 0.45%.

Market Cap

5.03b USD | # 2589 in US

Volume

1.92m shares | 113.76m USD

Shares Outstanding

95.99m

Free Float Shares

98.92% | 94.95m

News

TVTX key data

Travere Therapeutics (Nasdaq: TVTX) has a market capitalization of $5.03B. Last close $52.42 (as of 2026-11-05); 52-week range $22.59 to $68.73. ORTEX data as of 2026-11-03: short interest is 11.49% of free float, 4.6 days to cover and the average cost to borrow is 0.45%.

  • TVTX news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.